In both models, the administration of irisin resulted in a marked improvement in sarcopenia, confirmed by increased grip strength, muscle weight (greater in the gastrocnemium) and muscle fiber size, and reduced mRNA levels of atrophic and inflammatory genes and MAFbx and Murf-1 protein levels. Here, FNDC5 is linked to sarcopenia.